Raw and processed data can be downloaded from GEO under accession number GSE132642. In addition, processed data are also provided as Supporting Information.

Introduction {#sec001}
============

The immune system plays a critical role in identifying and destroying pathogens and nascent malignancies and is a key regulator in tissue homeostasis. Its age-associated decline in most mammalian species is concomitant with an age-dependent increase in chronic diseases \[[@pbio.3000528.ref001]\]. Unlike most mammals, the naked mole-rat (NM-R), a mouse-sized rodent, is cancer-resistant \[[@pbio.3000528.ref002]\], extremely long-lived relative to its body size \[[@pbio.3000528.ref003]\], and shows no age-associated exponential increase in risk of dying \[[@pbio.3000528.ref004]\], suggesting it maintains cellular and systemic homeostasis well into its third decade of life \[[@pbio.3000528.ref005],[@pbio.3000528.ref006]\]. An unexplored possibility is that the NM-R has evolved features of systemic immunity that contribute to these remarkable phenotypes.

Investigating the immune systems of non-model organisms, such as the NM-R, has traditionally been constrained by the lack of species-specific reagents. To circumvent these limitations, we used single-cell RNA-sequencing (scRNA-seq) to obtain an unbiased molecular profile of the immune systems of the NM-R and the well-characterized mouse, allowing us to compare their immune cell repertoires. We find that the cellular composition of the immune system of the NM-R is markedly different from that of the mouse. These differences include an inverted myeloid-to-lymphoid cell ratio, a novel lipopolysaccharide (LPS)-responsive granulocyte cell subset, and, most surprisingly, the absence of natural killer (NK) cells. The latter feature is supported by comparative genomics analyses, showing a lack of diversity in the gene families controlling NK cell function in other mammalian species.

Results {#sec002}
=======

The immune systems of the NM-R and mouse have strikingly different cellular compositions {#sec003}
----------------------------------------------------------------------------------------

In order to obtain cell repertoires of the NM-R and mouse immune systems, spleens were harvested from young healthy C57BL/6 mice (2--3 months old; *n* = 4) and NM-Rs (approximately 2 years old; *n* = 4) and a 10× Genomics \[[@pbio.3000528.ref007]\] droplet-based scRNA-seq library was prepared from each organ ([S1A--S1D](#pbio.3000528.s001){ref-type="supplementary-material"} and [S1H--S1K Fig](#pbio.3000528.s001){ref-type="supplementary-material"}). Gene-by-cell expression data were clustered separately for each species using an iterative approach (Materials and methods; [S1](#pbio.3000528.s013){ref-type="supplementary-material"} and [S2](#pbio.3000528.s014){ref-type="supplementary-material"} Tables). Subsequently, sets of marker genes were derived for each cluster ([S3](#pbio.3000528.s015){ref-type="supplementary-material"} and [S4](#pbio.3000528.s016){ref-type="supplementary-material"} Tables), thereby allowing their annotation and revealing the major immune cell subsets present in each species (Materials and methods; [Fig 1A--1D](#pbio.3000528.g001){ref-type="fig"}; [S1E](#pbio.3000528.s001){ref-type="supplementary-material"}, [S1G](#pbio.3000528.s001){ref-type="supplementary-material"}, [S1L and S1N Fig](#pbio.3000528.s001){ref-type="supplementary-material"}).

![scRNA-seq of mouse and NM-R spleens reveals major differences in immune cell populations.\
UMAP projections of four mouse (**A**) and four NM-R (**B**) spleens. Each point is a cell color-coded by its cluster assignment and annotated cell type (Materials and methods). The proportions (%) of cells assigned to each cell type in each species (excluding NM-R clusters of erythroid cells) are shown in the stacked bar charts. Gene-by-cell expression-level heatmaps in the mouse (**C**) and NM-R (**D**) spleens. Selected marker genes are listed to the left and cells are faceted by their cluster assignment. UMAP projections of the NM-R spleens color-coded by the expression levels of *Nkg7* and *Gzma* (**E**), *Cd3e* and *Cd8a* (**F**), and *Cpa3* (**G**). Gene-by-cell expression-level heatmap of the mouse spleen T cells and NK cell clusters and NM-R spleen T cells and mast cell clusters (**H**). APC, antigen-presenting cell; DC, dendritic cell; NK, natural killer; NKT, natural killer T; NM-R, naked mole-rat; RP, red pulp; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection; UMI, unique molecular identifier.](pbio.3000528.g001){#pbio.3000528.g001}

Consistent with previous reports \[[@pbio.3000528.ref008],[@pbio.3000528.ref009]\], the splenic immune cell population of mice is dominated by lymphoid lineage cells (approximately 90% of the cells; [Fig 1A and 1C](#pbio.3000528.g001){ref-type="fig"}). B cells (e.g., marked by *Cd19* and *Cd79a*) comprise 59% of the total splenic immune cell population; memory B cells (additionally marked by *Try5*) make up 2%, T cells (e.g., marked by the four cluster of differentiation \[CD\] 3 subunit genes: *Cd3g*, *Cd3e*, *Cd3g*, and *Cd247*) 28%, and NK cells (e.g., marked by *Ncr1*) 3%. Myeloid lineage cells account for the remaining 8%, breaking down to 7% antigen-presenting cells (APCs; e.g., marked by *Cd68*, *Ccl6*, and *C1qa*), which resolve to macrophage and dendritic cell subsets at the converged clusters ([S1E and S1F Fig](#pbio.3000528.s001){ref-type="supplementary-material"}), and 1% neutrophils (e.g., marked by *Cxcr2*).

By contrast, lymphoid lineage cells comprise only 44% of the splenic immune cell population in NM-Rs ([Fig 1B and 1D](#pbio.3000528.g001){ref-type="fig"}). Specifically, T cells (e.g., marked by the four CD3 subunit genes: *Cd3d*, *Cd3e*, *Cd3g*, and *Cd247*) account for 30% and B cells (e.g., marked by *Cd19* and *Cd79a*) 14%. The remaining 56% of the splenic immune cell population are myeloid lineage, with 10% macrophages (e.g., marked by *Cd68*, *C1qa*, and *C1qb*), 6% red-pulp macrophages (additionally marked by *Vcam-1* \[[@pbio.3000528.ref010]\]), and 37% neutrophils (e.g., marked by *Cxcr2*). Two separate clusters of neutrophils were identified; the larger cluster accounted for 36% of the cells and the smaller cluster, defined by not only the neutrophil expression profile but also by high expression of the antimicrobial lactotransferrin (*Ltf*), olfactomedin-4 (*Olfm4*), cathelicidin (*Camp*), and cysteine-rich secretory protein-1 (*Crisp1*), accounted for 1% of the splenic immune cells. We have termed these cells *Ltf*-high neutrophils. Dendritic cells (e.g., marked by *Cd74*) contribute to 2% of the splenic immune cells. These cells also showed high expression of *Timeless*, a gene associated with the regulation of circadian rhythm and protection of telomeres from DNA damage \[[@pbio.3000528.ref011]--[@pbio.3000528.ref013]\].

To confirm the interspecies differences we observed in our scRNA-seq data, we used comparative histomorphology and in situ hybridization (ISH; Materials and methods). This additionally revealed major interspecies differences in the distribution of the red and white pulp ([S2A Fig](#pbio.3000528.s002){ref-type="supplementary-material"}), with significantly higher expression of *Cd19* (B cell marker) and lower expression of *Cd14* (myeloid lineage marker) in the mouse than in the NM-R ([S2B--S2D Fig](#pbio.3000528.s002){ref-type="supplementary-material"}; [S5 Table](#pbio.3000528.s017){ref-type="supplementary-material"}). Moreover, while T cells were confined to the white pulp in mice, they were distributed more widely in NM-R spleens.

The immune system of the NM-R lacks canonical NK cells {#sec004}
------------------------------------------------------

Although lymphoid lineage cells were clearly detected in the NM-R spleen ([Fig 1B and 1D](#pbio.3000528.g001){ref-type="fig"}; [S1L](#pbio.3000528.s001){ref-type="supplementary-material"}, [S1M](#pbio.3000528.s001){ref-type="supplementary-material"} and [S2](#pbio.3000528.s002){ref-type="supplementary-material"} Figs), surprisingly, a cluster corresponding to NK cells was not identified. In mice, NK cells are marked by high expression of several genes, including *Ncr1*, *Gzma*, *Ccl5*, and *Nkg7* ([Fig 1C and 1H](#pbio.3000528.g001){ref-type="fig"}; [S3 Table](#pbio.3000528.s015){ref-type="supplementary-material"}). In NM-Rs, expression of *Ncr1* was detected neither in the scRNA-seq data nor in whole spleen RNA-sequencing data. By contrast, we did find high expression of *Gzma*, *Ccl5*, and *Nkg7* in a cell subset we identified as part of the T-cell cluster ([Fig 1D and 1H](#pbio.3000528.g001){ref-type="fig"}; [S1M](#pbio.3000528.s001){ref-type="supplementary-material"} and [S3A](#pbio.3000528.s003){ref-type="supplementary-material"} Figs). Similar to all other cell subsets within this T-cell cluster, this cell subset showed high expression of all four CD3 subunit genes: *Cd3d*, *Cd3e*, *Cd3g*, and *Cd247* and additionally is the only T-cell subset that showed high expression of *Cd8a*, consistent with its identity as CD8 T cells rather than NK cells ([Fig 1D and 1H](#pbio.3000528.g001){ref-type="fig"}; [S3B Fig](#pbio.3000528.s003){ref-type="supplementary-material"}; [S6 Table](#pbio.3000528.s018){ref-type="supplementary-material"}). Mouse NK cells showed negligible expression of these T-cell markers \[[@pbio.3000528.ref014]\] ([Fig 1B and 1H](#pbio.3000528.g001){ref-type="fig"}; [S1F Fig](#pbio.3000528.s001){ref-type="supplementary-material"}). Similarly, another NM-R cluster also showed high expression of *Gzma* and *Nkg7*, yet additionally showed high expression of *Cpa3*, *Tpsab1*, *Cma1*, and *Fcer1a*, in keeping with its identity as mast cells \[[@pbio.3000528.ref015]\] rather than NK cells ([Fig 1C and 1H](#pbio.3000528.g001){ref-type="fig"}; [S1M](#pbio.3000528.s001){ref-type="supplementary-material"} and [S3C](#pbio.3000528.s003){ref-type="supplementary-material"} Figs).

To exclude the possibility that the absence of NK cells in NM-Rs is specific to the spleen, we also performed scRNA-seq of circulating immune cells from an additional four C57BL/6 mice and four NM-Rs (Materials and methods; [S4A--S4D Fig](#pbio.3000528.s004){ref-type="supplementary-material"}; [S7](#pbio.3000528.s019){ref-type="supplementary-material"}--[S10](#pbio.3000528.s022){ref-type="supplementary-material"} Tables). A mouse NK cell cluster was readily detected, yet, again, NK cells were not detected in the NM-R ([S4E--S4H Fig](#pbio.3000528.s004){ref-type="supplementary-material"}). Finally, we tested the possibility that the observed lack of NK cells in our NM-R scRNA-seq data is a result of poor annotation of their marker genes in the NM-R genome. Simulating this situation in the mouse (Materials and methods), NK cells were still detected in a distinct cluster ([S5 Fig](#pbio.3000528.s005){ref-type="supplementary-material"}), suggesting that the absence of an NM-R NK cell cluster is not an artifact of genome annotation quality.

The NM-R genome lacks expanded gene families that control NK cell function {#sec005}
--------------------------------------------------------------------------

We sought an evolutionary genomic explanation for the absence of NM-R NK cells and therefore examined the genes whose products control NK cell function. These include genes encoding NK cell receptors and their major histocompatibility complex class I (MHC-I) ligands \[[@pbio.3000528.ref016]\]. In mammals, NK cell receptors are encoded in two distinct gene complexes: the leukocyte receptor complex (*LRC*) and the natural killer cell receptor complex (*NKC*). The *LRC* predominantly contains genes encoding immunoglobulin superfamily receptors, including killer cell immunoglobulin-like receptors (*KIRs*) that have dramatically expanded in Old World monkeys and apes \[[@pbio.3000528.ref017]\]; the *NKC* contains gene families encoding killer cell lectin-like receptors such as *Cd94* (*Klrd*), *Nkg2* (*Klrc*), and *Ly49* (*Klra*), where the latter has dramatically expanded in the muriods \[[@pbio.3000528.ref018]\]. We compared the NM-R *LRC*, *NKC*, and *MHC-I* genes to those of the human and mouse, in which they are well characterized. Consistent with its phylogeny, the NM-R *LRC*, like that of the mouse, does not harbor an expanded *KIR* family ([Fig 2A](#pbio.3000528.g002){ref-type="fig"}; [S11 Table](#pbio.3000528.s023){ref-type="supplementary-material"}). However, in stark contrast to the mouse, the NM-R *NKC* does not have an expanded *Ly49* gene family, harboring only a single protein-coding *Ly49* gene (*LOC101714034*; a mouse *Klra1* ortholog). This gene, which is predicted to encode a classical inhibitory MHC-I receptor ([S6A Fig](#pbio.3000528.s006){ref-type="supplementary-material"}), is expressed at low levels in NM-R CD8 T cells, whereas its mouse ortholog is highly expressed in mouse CD8 T cells, as well as in NK cells ([S6B and S6C Fig](#pbio.3000528.s006){ref-type="supplementary-material"}, respectively). Moreover, unlike the diversity of *MHC-I* genes in the human and mouse genomes (with both 6 and 22 protein-coding genes, as well as 7 and 14 pseudogenes, respectively), the NM-R genome has only three *MHC-I* genes (two protein-coding genes and one pseudogene) ([Fig 2C](#pbio.3000528.g002){ref-type="fig"}). These data suggest that NM-Rs lack the control mechanisms of canonical NK cells, supporting our scRNA-seq findings that NM-Rs lack NK cells.

![The NM-R genome lacks expanded NK cell receptor and MHC-I gene families.\
Schematic diagram of the linear arrangement of genes, in 5′ -3′ genomic orientation relative to the human genome, in the *LRC* (**A**), *NKC* (**B**), and *MHC-I* loci (**C**) of the human, mouse, and NM-R genomes. Boxes represent the genes encoding NK cell receptors and their ligands---MHC-I, which are known to control NK cell function, color-coded by family. Synteny markers (gray boxes) are genes that flank the human *LRC*, *NKC*, and *MHC-I* loci; (**D**) phyletic pattern showing the numbers of protein-coding genes (P) and annotated pseudogenes (Ψ) (in the *LRC*, *NKC*, and *MHC-I* loci), as well as putative pseudogenes (ψ) (only in the *NKC* and *MHC-I* loci) across 48 mammalian genomes (Materials and methods). Overlaid on the phylogeny are the maximum parsimony--reconstructed ancestral numbers of the *Ly49* (*KLRA*) gene family. Color shades in both the phyletic pattern and ancestral *Ly49* counts correspond to the numbers of genes. Ancestral *Ly49* counts are represented as pie charts in which the slice sizes correspond to the probability of each count. In all phylogenies, order names are indicated and faceted by the gray and blue background colors. Chr, chromosome; *LRC*, leukocyte receptor complex; *MHC-I*, major histocompatibility complex class I; NK, natural killer; *NKC*, natural killer cell receptor complex; NM-R, naked mole-rat.](pbio.3000528.g002){#pbio.3000528.g002}

In order to understand how widespread this lack of species-level diversity in NK cell receptor and *MHC-I* genes is, we expanded our analysis to include 45 additional mammalian genomes, among them several members of the same suborder of rodents to which the NM-R belongs (Hystricomorpha). Our analysis additionally included the detection of old and hence unannotated NK cell receptor and *MHC-I* pseudogenes in order to reconstruct their evolutionary histories (Materials and methods; [S7 Fig](#pbio.3000528.s007){ref-type="supplementary-material"}, [S12](#pbio.3000528.s024){ref-type="supplementary-material"} and [S13](#pbio.3000528.s025){ref-type="supplementary-material"} Tables). This revealed that the *Ly49* gene family expanded from the single ancestral gene to three members prior to the Lagormorpha-Rodentia split ([Fig 2D](#pbio.3000528.g002){ref-type="fig"}). Subsequently, the *Ly49* family went through several expansions and contractions along the muroid lineage, leading to the highly diversified *Ly49* gene family in the mouse and rat and the large array of pseudogenes in all other muroid genomes. This finding is largely mirrored by their *MHC-I* patterns ([Fig 2D](#pbio.3000528.g002){ref-type="fig"}), consistent with their reported coevolution \[[@pbio.3000528.ref016]\]. Interestingly, among the examined hystricomorphs, only the guinea pig retained all three ancestral *Ly49* genes, and in addition to its six protein-coding *MHC-I* genes, it was found to harbor 19 *MHC-I* pseudogenes ([Fig 2D](#pbio.3000528.g002){ref-type="fig"}). By contrast, the NM-R as well as the other two hystricomorphs for which genome data are available lost either two or all three of their *Ly49* genes. Accordingly, their genomes were also found to harbor dramatically lower numbers of both protein-coding and pseudo *MHC-I* genes ([Fig 2D](#pbio.3000528.g002){ref-type="fig"}), suggesting that within these hystricomorphs, only the guinea pig has retained the control mechanisms of canonical NK cells. Intriguingly, the guinea pig is known to have a population of atypical, histologically distinct mononuclear cells (Foa-Kurloff cells) with reported NK-like activity \[[@pbio.3000528.ref019],[@pbio.3000528.ref020]\]. Although we readily detected these cells in a guinea pig peripheral blood smear ([S6D Fig](#pbio.3000528.s006){ref-type="supplementary-material"}), we did not detect morphologically similar cells in NM-R peripheral blood smears ([S6E--S6I Fig](#pbio.3000528.s006){ref-type="supplementary-material"}), further supporting the premise that NM-Rs lack NK cells. We cannot rule out, however, that other cell types may have NK-like activity in the NM-R.

The immune system of the NM-R contains an LPS-responsive granulocyte cell subset {#sec006}
--------------------------------------------------------------------------------

The abundance of myeloid lineage cells in the NM-R that strongly express the toll-like receptor (TLR) 4 co-receptor *Cd14* (which together recognize bacterial LPS and other pathogen-associated molecules \[[@pbio.3000528.ref021]\]), as well as their striking absence of NK cells raises the question whether the NM-R immune system has evolved unique innate responses to bacterial infections. To address this question, we profiled gene expression from spleens and circulating immune cells in mice and NM-Rs following in vivo LPS administration, mimicking an acute bacterial infection.

Significant changes in gene expression following LPS challenge were evident in whole spleen RNA-sequencing ([S8A--S8D Fig](#pbio.3000528.s008){ref-type="supplementary-material"}; [S14](#pbio.3000528.s026){ref-type="supplementary-material"} and [S15](#pbio.3000528.s027){ref-type="supplementary-material"} Tables). Gene set enrichment analyses (GSEAs) revealed that both species activated similar pathways, including the canonical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) inflammatory pathway ([S8E and S8F Fig](#pbio.3000528.s008){ref-type="supplementary-material"}; [S16](#pbio.3000528.s028){ref-type="supplementary-material"} and [S17](#pbio.3000528.s029){ref-type="supplementary-material"} Tables). Spleen scRNA-seq revealed that cells from both saline control and LPS-challenged animals of both species clustered into similar cell types to those observed in untreated animals ([Fig 3A and 3B](#pbio.3000528.g003){ref-type="fig"}; [S18](#pbio.3000528.s030){ref-type="supplementary-material"}--[S25](#pbio.3000528.s037){ref-type="supplementary-material"} Tables). A differential gene expression analysis between LPS-challenged and saline control animals indicated changes in the proportion of cells expressing a certain gene (expression-induction) as the predominant driver of the transcriptional responses ([S9A--S9G Fig](#pbio.3000528.s009){ref-type="supplementary-material"}; [S26](#pbio.3000528.s038){ref-type="supplementary-material"}--[S28](#pbio.3000528.s040){ref-type="supplementary-material"} Tables).

![Spleen scRNA-seq reveals that NM-Rs have an LPS-responsive cell subset not found in mice.\
UMAP projections showing cell clusters from two saline control (left panel) and two LPS-challenged (right panel) mouse (**A**) and NM-R (**B**) spleens. Each point is a cell color-coded by its cluster assignment and annotated cell type (Materials and methods). Stacked bar charts show the proportions (%) of cells assigned to each cell type in the saline control (left) and LPS-challenged (right) mouse (**C**) and NM-R (**D**) spleens. UMAP projections showing cell clusters representing *Ltf*-high neutrophils (pink) and neutrophils (yellow) from saline control (**E**) and LPS-challenged (**F**) NM-R spleens. Overlaid on each cluster are arrows that represent the cell trajectory (see [Materials and methods](#sec008){ref-type="sec"}). Bar charts show GSEAs comparing *Ltf*-high neutrophils to neutrophils from saline control (see [S29 Table](#pbio.3000528.s041){ref-type="supplementary-material"} for underlying data) (**G**) and LPS-challenged (see [S30 Table](#pbio.3000528.s042){ref-type="supplementary-material"} for underlying data) (**H**) NM-R spleens. X-axes are the GSEA log~10~-adjusted *p*-values (*q*-values), signed and color-coded by the direction of the effect (up- and down-regulation in *Ltf*-high neutrophils versus neutrophils: yellow and cyan, respectively). Black vertical dashed lines mark adjusted *p* = 0.1. DC, dendritic cell; GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NK, natural killer; NM-R, naked mole-rat; pDC, plasmacytoid dendritic cell; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.](pbio.3000528.g003){#pbio.3000528.g003}

The most striking species difference we observed following the LPS challenge was the change in the proportion of immune cells assigned to each NM-R cluster ([Fig 3C and 3D](#pbio.3000528.g003){ref-type="fig"}). Most notable were the dramatic increase of *Ltf*-high neutrophils (from approximately 5% to \>25%; adjusted *p* \< 10^−22^) and decrease in neutrophils (from 26% to 18%; adjusted *p* \< 10^−22^). The increase of *Ltf*-high neutrophils in LPS-challenged NM-Rs was accompanied by a convergence between the neutrophil and *Ltf*-high neutrophil clusters in the uniform manifold approximation and projection (UMAP) \[[@pbio.3000528.ref022]\] embedding space ([Fig 3B](#pbio.3000528.g003){ref-type="fig"}). In addition, unlike in the saline control, the trajectories of NM-R LPS-challenged neutrophils trended towards *Ltf*-high neutrophils ([Fig 3B, 3E, and 3F](#pbio.3000528.g003){ref-type="fig"}). GSEA of genes differentially expressed between the saline control *Ltf*-high neutrophils and neutrophils indicated mainly down-regulation (adjusted *p* \< 0.1) of chemotaxis pathways in *Ltf*-high neutrophils (or up-regulation in neutrophils) ([Fig 3G](#pbio.3000528.g003){ref-type="fig"}; [S29 Table](#pbio.3000528.s041){ref-type="supplementary-material"}). A similar analysis in the LPS-challenged NM-Rs showed up-regulation of humoral immune responses mediated by antimicrobial peptides and down-regulation of viral replication processes, host--pathogen interactions, and negative regulation of immune cell proliferation in *Ltf*-high neutrophils (both adjusted *p* \< 0.1) ([Fig 3H](#pbio.3000528.g003){ref-type="fig"}; [S30 Table](#pbio.3000528.s042){ref-type="supplementary-material"}). Qualitatively similar results were observed in NM-R circulating immune cells ([S10 Fig](#pbio.3000528.s010){ref-type="supplementary-material"}; [S31](#pbio.3000528.s043){ref-type="supplementary-material"}--[S42](#pbio.3000528.s054){ref-type="supplementary-material"} Tables). These results strongly suggest that NM-Rs have two transcriptionally distinct but functionally integrated neutrophil populations that likely play an important role in innate antimicrobial immunity in this species.

Discussion {#sec007}
==========

Our investigation of the NM-R and mouse immune systems reveal striking differences in their cell repertoires. We find that the immune system of the NM-R is heavily reliant on innate myeloid lineage cells, lacks NK cells, and contains a previously undescribed, transcriptionally distinctive cell subset that is highly responsive to a bacterial-mimicking challenge.

To the best of our knowledge, our study is the first to report a mammalian species that lacks a clearly defined population of NK cells that form the first line of defense against viral infections and play an important role in cancer immunosurveillance \[[@pbio.3000528.ref023]\]. The lack of NM-R NK cells is supported by a dearth of genes that regulate NK cell function (encoding NK cell receptors and their MHC-I ligands), a feature common to both the human and mouse genomes, in which NK cells have been well characterized. Notwithstanding, allelic and structural polymorphisms are common features of NK cell receptor and *MHC-I* genes \[[@pbio.3000528.ref016]\], and because our study does not include population-level genomic data, their true genetic (and functional) diversity in the NM-R may be underestimated. However, population-level diversity typically adds to the species-level diversity of these genes (e.g., *KIR* in humans \[[@pbio.3000528.ref016]\] and *Ly49* in mouse \[[@pbio.3000528.ref018]\]), and a similar lack of gene diversity has been previously documented in several marine carnivores (seals and sea lions) at both the species and population levels \[[@pbio.3000528.ref024]\]. In addition, our evolutionary analysis of NK cell receptor genes provides strong support to a scenario in which a common hystricomorph ancestor had NK-like cells, which, along with *Ly49* pseudogenization, were subsequently lost in NM-Rs and other hystricomorph rodents, possibly in response to a relaxation in pathogenic selective pressures. The low *MHC-I* gene diversity in these hystricomorphs supports this scenario, as high numbers of protein-coding and pseudo *MHC-I* genes are reflective of high rates of gene birth and death in response to pathogens \[[@pbio.3000528.ref025]\].

The lack of NK cells and accompanying low diversity in the genes encoding their control mechanisms, together with the predominance of the myeloid lineage and its novel LPS-responsive, antimicrobial gene--expressing neutrophil-like subset, indicate that NM-Rs strongly rely on myeloid-based innate immunity. Taken together, these suggest that the NM-R immune system has evolved under stronger antibacterial than antiviral immune selective pressures. Additional support for this conclusion are two reports that NM-Rs are highly susceptible to viral infection \[[@pbio.3000528.ref026],[@pbio.3000528.ref027]\]. Given their ecological niche and atypical mammalian behavior, it is possible that these xenophobic, eusocial, and strictly subterranean rodents naturally experience weaker viral selective pressures than other species such as bats, which live in open, typically crowded colonies, where intricate antiviral defenses are essential \[[@pbio.3000528.ref028]\].

Finally, the manner by which its unusual immune features impact upon better maintenance of tissue homeostasis, prolonged health span, and especially cancer resistance in the NM-R and possibly other species with similar immune features remains to be elucidated.

Materials and methods {#sec008}
=====================

Ethics statement {#sec009}
----------------

All animal use and experiments were approved by the Buck Institute institutional animal care and use committee (IACUC) protocol number A10173.

Animals {#sec010}
-------

In this study, we used comparative histomorphology, comparative genomics, fluorescent ISH, and whole-tissue as well as single-cell gene expression to study the immune system of the NM-R in comparison with that of the mouse and other mammalian species. The animals used for RNA-seq in this study comprised 12 young C57BL/6 mice (8 to 10 weeks old; six males, six females, all virgins) and 12 young NM-Rs (23 to 25 months old; six males, six females, all nonbreeders). For blood smears, two young female guinea pigs (approximately 2 years old) and an additional five young nonbreeding NM-Rs (2 to 15 months old; three males, two females) were used. The NM-Rs in this study came from 10 different captive colonies, while the mice were purchased from the Jackson Laboratories (Bar Harbor, ME) and maintained in the vivarium for at least 2 weeks prior to use. The age range we selected was targeted to use young, healthy individuals that were physiologically age-matched between the species (approximately 5%--10% of observed maximum life span). Both species were maintained on a 12-hour dark-light cycle and provided food ad libitum. Mice were provided water ad libitum. In accordance with standard colony management, NM-Rs did not receive supplemented water, as the water content of their diet is sufficient for maintaining appropriate hydration.

Organ collection and processing {#sec011}
-------------------------------

We investigated the immune cell repertoire of eight NM-Rs (four males, four females) and eight C57BL/6 mice (four males, four females) using scRNA-seq of the spleen and circulating immune cells. Organ collection was performed on all animals between 8 AM and 10 AM. Animals were anesthetized using isoflurane. Blood was drawn via cardiac puncture and immediately transferred into EDTA-containing tubes, mixed by inversion, and placed on ice.

1.  Blood: One milliliter of EDTA-treated blood was resuspended in 20 mL ACK lysis buffer (Gibco A1049201, Waltham, MA) for 5 minutes at 21°C. Cells were pelleted (500*g*, 10 minutes, 4°C), resuspended in PBS with 5% FBS, and washed twice. Following resuspension, cells were passed through a 40-μm filter and placed on ice prior to determination of viability and density. Visual inspection of trypan blue (Gibco 15250061, Waltham, MA) stained cells loaded on a hemocytometer slide was used to determine the density and viability of cells in the suspension.

2.  Spleen: Immediately following cardiac exsanguination, the spleen was removed by dissection, transferred to a sterile petri dish containing PBS with 5% FBS, and minced using razors. Following trituration with a 5-mL serological pipette, the spleen fragments were ground through 100-μm and 40-μm cell strainers (Falcon 352360 and 352340, Corning, NY) with a syringe plunger. Cells were pelleted (500*g*, 10 minutes, 4°C), resuspended in 20 mL of ACK lysis buffer (Gibco A1049201, Waltham, MA) for 5 minutes at 21°C, and washed twice with PBS with 5% FBS. Following resuspension, cells were passed through a 40-μm filter and placed on ice prior to determination of viability and density. Visual inspection of trypan blue (Gibco 15250061, Waltham, MA) stained cells loaded on a hemocytometer slide was used to determine the density and viability of cells in the suspension.

LPS challenge {#sec012}
-------------

In order to study the transcriptional response of mice and NM-Rs to stimulation of the innate immune system, we performed transcriptional profiling 4 hours following an LPS challenge. Two animals from each species (one male, one female) were randomly assigned into either LPS challenge or saline control groups (total = four mice, four NM-Rs). Saline control animals received intraperitoneal injection of 200 μL sterile saline. LPS-challenged animals received intraperitoneal injection of 1 mg/kg LPS (LPS-EB VacciGrade, *Escherichia coli* 0111:B4, Invivogen, San Diego, CA), prepared in sterile saline to a final volume of 200 μL. The body temperature of all animals was monitored by rectal probe every 30 minutes for 2 hours following injection. Collection and processing of blood and spleen were performed 4 hours following initial injection and as described above, with the exception that approximately one fifth of each spleen was immediately flash-frozen in liquid nitrogen (for whole-tissue RNA extraction and sequencing).

scRNA-seq and data analysis {#sec013}
---------------------------

Single cells were captured in droplet emulsion using the Chromium Controller (10× Genomics, Pleasanton, CA), and scRNA-seq libraries were constructed according to the 10× Genomics protocol using the Chromium Single-Cell 3′ Gel Bead and Library V2 Kit (10× Genomics, Pleasanton, CA). In brief, cell suspensions were diluted in PBS with 5% FBS to a final concentration of 1 × 10^6^ cells/mL (1,000 cells per μL). Cells were loaded in each channel with a target output of 3,000 cells per sample. All reactions were performed in a C1000 Touch Thermal Cycler (Bio-Rad Laboratories, Hercules, CA) with a 96 Deep Well Reaction Module. Twelve cycles were used for cDNA amplification and sample index PCR. Amplified cDNA and final libraries were evaluated using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) with a high sensitivity chip. Samples were sequenced on an HiSeq 4000 instrument (Illumina, San Diego, CA).

scRNA-seq fastq files were demultiplexed to their respective barcodes using the 10× Genomics Cell Ranger mkfastq utility. Unique molecular identifier (UMI) counts were generated for each barcode using the Cell Ranger count utility. The mm10 reference genome and the mouse Gencode version M12 annotation were used for mapping the mouse reads \[[@pbio.3000528.ref029]\]. The HetGla2.0 reference genome along with the RefSeq GCF_000247695.1 annotation, to which we manually added the annotation of the *Ncr1* gene from Ensembl's *H*. *glaber* female genome annotation (which is the only NM-R genome annotation that covers this gene), were used for mapping the NM-R reads. For each sample, barcodes that were not likely to represent captured cells were filtered out by detecting the first local minimum above 2 in a distribution of log~10~(\#UMIs). Similarly, for each sample, genes that were too sparsely captured across barcodes were filtered out by detecting the first local minimum above 3 in a distribution of log~10~(\#barcodes). Finally, barcodes capturing more than a single cell (multiplets) were sought as local modes in the distributions of log~10~(\#genes) and log~10~(\#UMIs), whose x-axis maxima are more than 1.5 times higher than the x-axis location of the global maximum of the respective distribution and include less than 5% of the total number of barcodes. In other words, barcodes that, based on the number of genes or UMIs they captured, appeared inflated with respect to all other barcodes, were regarded as multiplets and thus filtered out (summary statistics shown in [S43 Table](#pbio.3000528.s055){ref-type="supplementary-material"}).

To identify cell clusters, the samples from each species were concatenated, UMIs were then scaled to the read depth of their respective barcodes, and genes with high expression dispersion were obtained using Seurat \[[@pbio.3000528.ref030]\] ([S43 Table](#pbio.3000528.s055){ref-type="supplementary-material"}). Principal components analysis (PCA) was then performed on these gene-by-cell--scaled UMI matrices using the rsvd \[[@pbio.3000528.ref031]\] R \[[@pbio.3000528.ref032]\] package to reduce their genes dimension, retaining the 50 PCs explaining the highest amount of variation. We then used Seurat's methodology to build a shared nearest neighbor (SNN) graph of these cell-embedding data, first generating a k-nearest neighbor (KNN) graph using k = min(750, \#cells-1) and a Jaccard distance cutoff of 1/15. The SNN graph was then used as input to the Louvain algorithm, implemented in the ModularityOptimizer software \[[@pbio.3000528.ref033]\]. Because this implementation uses a resolution parameter that strongly affects the number of clusters, we searched the 0.05--1.225 range of this parameter, using the mean unifiability isolability clustering metric as our maximization parameter. This process was initially done on all cells in our data and subsequently repeated for each cluster individually, in an iterative manner in which convergence was defined as not being able to break down a cluster into subclusters (see [S1](#pbio.3000528.s013){ref-type="supplementary-material"}, [S2](#pbio.3000528.s014){ref-type="supplementary-material"}, [S7](#pbio.3000528.s019){ref-type="supplementary-material"}, [S8](#pbio.3000528.s020){ref-type="supplementary-material"}, [S18](#pbio.3000528.s030){ref-type="supplementary-material"}--[S21](#pbio.3000528.s033){ref-type="supplementary-material"} and [S31](#pbio.3000528.s043){ref-type="supplementary-material"}--[S34](#pbio.3000528.s046){ref-type="supplementary-material"} Tables for the cell-cluster assignments for each species-tissue-condition dataset).

In order to obtain gene markers for each cluster, we applied a differential expression test implemented in Seurat (using a likelihood ratio test between a model that assumes that a gene's expression values of two compared clusters were sampled from two distributions, versus a null model, which assumes they were sampled from a single distribution). The clusters that were used for this procedure were the ones obtained following convergence of our iterative clustering approach. A marker gene of a given converged cluster was thus defined as a gene that was found to be significantly overexpressed (multiple-hypotheses--adjusted *p* \< 0.05) in that converged cluster compared to all other converged clusters (see [S3](#pbio.3000528.s015){ref-type="supplementary-material"}, [S4](#pbio.3000528.s016){ref-type="supplementary-material"}, [S9](#pbio.3000528.s021){ref-type="supplementary-material"}, [S10](#pbio.3000528.s022){ref-type="supplementary-material"}, [S22](#pbio.3000528.s034){ref-type="supplementary-material"}--[S25](#pbio.3000528.s037){ref-type="supplementary-material"} and [S35](#pbio.3000528.s047){ref-type="supplementary-material"}--[S38](#pbio.3000528.s050){ref-type="supplementary-material"} Tables for the converged cluster marker genes for each species-tissue-condition dataset). In all genes-by-cells heatmap figures, the total number of cells was reduced to a maximum of 2,500 (in proportions with respect to the number of cells per cluster) by randomly down-sampling cells in each cluster.

Cell types were assigned to the transcriptionally defined clusters in our data by intersecting the sets of marker genes we obtained for each cluster with immune cell expression data in transcripts per million (TPM) units, downloaded from the ImmGen portal \[[@pbio.3000528.ref034]\], obtained by RNA-seq of sorted mouse immune cell types ([S44 Table](#pbio.3000528.s056){ref-type="supplementary-material"}). Based on the ImmGen expression data, we subsequently only used the marker genes that were found to be strongly and specifically expressed in a specific ImmGen cell type. As a result, visualizing the ImmGen TPM expression levels of the retained marker genes for each cluster clearly identified the cell types corresponding with the first-iteration clusters.

In both the spleen and circulating immune cell NM-R scRNA-seq datasets, our clustering approach isolated one or more clusters that showed high expression levels of the beta and alpha adult hemoglobin genes. However, slightly lower expression levels of these two genes were also observed in all other clusters ([S11A](#pbio.3000528.s011){ref-type="supplementary-material"}, [S11D](#pbio.3000528.s011){ref-type="supplementary-material"} and [S12A](#pbio.3000528.s012){ref-type="supplementary-material"}, [S12D](#pbio.3000528.s012){ref-type="supplementary-material"} Figs in spleen and circulating immune cells, respectively), which probably represents RNA released from lysed red blood cells, yet captured and sequenced by essentially all barcodes. Notwithstanding, the same clusters that showed high expression levels of the beta and alpha hemoglobin genes also showed isolated lower expression levels of the embryonic and fetal hemoglobin genes (epsilon, theta, and zeta, yet not of gamma) ([S11B](#pbio.3000528.s011){ref-type="supplementary-material"}, [S11C](#pbio.3000528.s011){ref-type="supplementary-material"} and [S12B](#pbio.3000528.s012){ref-type="supplementary-material"}, [S12C](#pbio.3000528.s012){ref-type="supplementary-material"} Figs in spleen and circulating immune cells, respectively). This is in contrast to the mouse spleen and circulating immune cell scRNA-seq datasets, which showed nominal and nonspecific expression levels only of the adult beta and alpha hemoglobin genes ([S11G--S11J](#pbio.3000528.s011){ref-type="supplementary-material"} and [S12G--S12J](#pbio.3000528.s012){ref-type="supplementary-material"} Figs in spleen and circulating immune cells, respectively). It should be noted that the red-blood-cell lysis protocols we used were designed and optimized for the mouse and not the NM-R; hence, these species differences may reflect suboptimal lysis efficiency in the NM-R, possibly contributed by differences in the cell membrane components between the two species. We additionally compared the number of genes expressed in the NM-R hemoglobin-expressing clusters to the mean number of genes expressed across all NM-R clusters. In the spleen, this comparison did not indicate that these clusters express a much narrower range of genes compared with the immune cells ([S11K Fig](#pbio.3000528.s011){ref-type="supplementary-material"}; [S45 Table](#pbio.3000528.s057){ref-type="supplementary-material"}), unlike in the circulating immune cell data ([S12K Fig](#pbio.3000528.s012){ref-type="supplementary-material"}; [S46 Table](#pbio.3000528.s058){ref-type="supplementary-material"}). Taken together, we suspect that these clusters correspond to immature red blood cells, possibly in different maturation stages between the spleen and blood, and hence labeled them as erythroid cells, yet refrained from any further investigation as it fell outside the scope of this work.

In Figs [1A--1G](#pbio.3000528.g001){ref-type="fig"}, [3A](#pbio.3000528.g003){ref-type="fig"}, [3B](#pbio.3000528.g003){ref-type="fig"}, [3E and 3F](#pbio.3000528.g003){ref-type="fig"}; [S2B](#pbio.3000528.s002){ref-type="supplementary-material"}, [S3A](#pbio.3000528.s003){ref-type="supplementary-material"}, [S3C](#pbio.3000528.s003){ref-type="supplementary-material"}, [S4E--S4H](#pbio.3000528.s004){ref-type="supplementary-material"}, [S5A--S5C](#pbio.3000528.s005){ref-type="supplementary-material"}, [S10A and S10B](#pbio.3000528.s010){ref-type="supplementary-material"} Figs, the clusters that are represented are those obtained following the first iteration of our clustering approach. In [S1E--S1G](#pbio.3000528.s001){ref-type="supplementary-material"}, [S1L](#pbio.3000528.s001){ref-type="supplementary-material"}, [S1M](#pbio.3000528.s001){ref-type="supplementary-material"}, [S3B](#pbio.3000528.s003){ref-type="supplementary-material"}, [S5D](#pbio.3000528.s005){ref-type="supplementary-material"}, [S11](#pbio.3000528.s011){ref-type="supplementary-material"} and [S12](#pbio.3000528.s012){ref-type="supplementary-material"} Figs, the clusters that are represented are those obtained following convergence of our clustering approach.

Obtaining a phyletic pattern of protein-coding genes, annotated pseudogenes, and putative pseudogenes in the *LRC*, *NKC*, and *MHC-I* region {#sec014}
---------------------------------------------------------------------------------------------------------------------------------------------

In order to detect any possible present and past members of any of the NK cell receptor gene families in the *LRC* and *NKC*, as well as of *MHC-I* genes, we followed a two-step approach. First, we used the OrthoFinder software, which finds groups of orthologous genes based on amino-acid sequence homology \[[@pbio.3000528.ref035]\]. Specifically, OrthoFinder was used with 48 mammalian proteome sequences ([S47 Table](#pbio.3000528.s059){ref-type="supplementary-material"}). The resulting orthogroups were then assigned to each one of the gene families based on the genome annotations in which members of these gene families were annotated. In order to include annotated pseudogenes, we augmented this step with applying a reciprocal best BLASTn \[[@pbio.3000528.ref036]\] hit search between all pairs of the 48 mammalian transcriptomes ([S47 Table](#pbio.3000528.s059){ref-type="supplementary-material"}), retaining only hits with an e-value \<0.1 and a sequence identity \>80%. Any annotated pseudogene that hit any protein-coding member, which belong to any of the gene family orthogroups, was thus additionally included in that gene family orthogroup. Second, we used each of the transcript sequences from each of the orthogroups as queries against each of the 48 mammalian genomes ([S47 Table](#pbio.3000528.s059){ref-type="supplementary-material"}) for a SIM \[[@pbio.3000528.ref037]\] sequence homology search, which is purposed for aligning expressed sequence tags (ESTs) against genome sequences. Each SIM hit with at least 40% identity to the query sequence was retained. Subsequently, overlapping hits from different queries of the same gene family were merged, and the merged hit was used as query for a reverse position-specific (RPS) BLAST \[[@pbio.3000528.ref038]\] search against conserved protein domains. Specifically, for the *KIR* and *LILR* gene families, we retained any "Ig LILR KIR like" domain hit; for the *KLRA* gene family we retained any "Ly49" domain hit; for all other NK cell receptor gene families (*KLRB*-*K*), we retained any "CLECT NK receptors like" domain hit; and for *MHC-I* genes, we retained any "MHC_I", "MHC_I\_C", or "IgC_MHC_I\_alpha3" domain hit. In all cases, any of the domain hits with either e-value ≥0.1 or identity ≤60% were filtered. We additionally required that all these SIM and RPS-BLAST hits be located on the scaffolds of either the *LRC*, *NKC*, or *MHC-I* locus of the corresponding gene queries, and for the purpose of detecting putative (i.e., unannotated) pseudogenes, annotated genes (protein-coding and pseudogenes) were ignored ([S13 Table](#pbio.3000528.s025){ref-type="supplementary-material"}). In order to benchmark the false positive rate of this approach, for each of the gene families we counted how many of the hits covering annotated genes (protein-coding and pseudogenes) belong to the same gene family of the query ([S12 Table](#pbio.3000528.s024){ref-type="supplementary-material"}). Because the percentage of false positives for the *LILR* and *KIR* gene families was unreasonably high, likely stemming from the confounding fact that their defining domain is shared ("Ig LILR KIR like"), we refrained from interpreting these hits as putative pseudogenes.

Reconstructing the ancestral numbers of NK cell receptor gene families {#sec015}
----------------------------------------------------------------------

In order to reconstruct the number of genes in each of the NK cell receptor families in each ancestral node in the phylogeny (obtained from the Ensembl database), we combined the numbers of protein-coding genes, annotated pseudogenes, and putative pseudogenes for each of the NK cell receptor gene families, except for *LILR* and *KIR*, and subsequently used that as the phylogeny tip states input for the asr_max_parsimony function of the castor \[[@pbio.3000528.ref039]\] R \[[@pbio.3000528.ref032]\] package, to reconstruct ancestral states using the Sankoff maximum parsimony algorithm with a cost matrix proportional to the number of genes.

Obtaining a list of mouse--NM-R orthologous genes {#sec016}
-------------------------------------------------

To obtain mouse--NM-R one-to-one gene orthologs for the purpose of differential expression and GSEAs, we applied a reciprocal-blast approach \[[@pbio.3000528.ref036]\]. Specifically, we used BLASTp for each of the NM-R protein sequences against all mouse protein sequences and vice versa, and the same for transcript sequences using BLASTn. In both cases, we retained only hits with e-value \<0.1 and a sequence identity \>80%. Any gene for which any of its protein or transcript forms reciprocally hit back any of the protein or transcript forms of that gene was retained as a one-to-one gene ortholog ([S48 Table](#pbio.3000528.s060){ref-type="supplementary-material"}).

Cell type--specific responses to LPS challenge {#sec017}
----------------------------------------------

In single-cell data (including the data generated in this study), the distribution of the number of UMIs per a given gene across the cells in a certain cluster is typically bimodal, with a left mode located at zero and a right mode located at higher than zero. Across different factors (e.g., treatments, different cell types), a change in the proportion of cells expressing the gene, i.e., a change in expression-induction, can be explicitly quantified, as well as the change in the levels of expression among the cells expressing the gene (i.e., a shift in the right modes of the distributions of the number of UMIs). To this end, in all our differential expression analyses, with the exception of the one applied for defining cluster marker genes, we fitted a hurdle generalized linear mixed model to the data using the lme4 \[[@pbio.3000528.ref040]\] R \[[@pbio.3000528.ref032]\] package. Specifically, effects on expression-induction were estimated by fitting a logistic mixed-effects regression model (with a binomial family using the logit link function) by binarizing the outcome to 0 (not expressed in the cell) and 1 (expressed in the cell). Effects on expression levels were estimated by fitting a mixed-effects regression model (with a gamma family using the log link function) only to the cells in which the gene was expressed. In both cases, sample was defined as a random effect.

In order to detect intraspecies cell type--specific responses following LPS challenge, for each gene in each pair of matching cell types in the saline control and LPS challenge datasets ([S49](#pbio.3000528.s061){ref-type="supplementary-material"} and [S50](#pbio.3000528.s062){ref-type="supplementary-material"} Tables for the datasets of the spleen and circulating immune cells, respectively), we fitted the hurdle model described above to the LPS challenge and saline control data. Specifically, to estimate the effect of LPS challenge on induction of expression as well as on change of expression levels, LPS challenge was specified as a fixed categorical effect, with saline control set as baseline, and sample was specified as a random effect, as noted above. Heatmaps displaying the expression-level and expression-induction changes were limited to the set of one-to-one gene orthologs between mouse and NM-R ([S48 Table](#pbio.3000528.s060){ref-type="supplementary-material"}) and to cell types we matched between them ([S49](#pbio.3000528.s061){ref-type="supplementary-material"} and [S50](#pbio.3000528.s062){ref-type="supplementary-material"} Tables for the datasets of the spleen and circulating immune cells, respectively). Interspecies heatmaps were generated by matching mouse and NM-R cell types across the LPS challenge and saline control conditions ([S51](#pbio.3000528.s063){ref-type="supplementary-material"} and [S52](#pbio.3000528.s064){ref-type="supplementary-material"} Tables for the datasets of the spleen and circulating immune cells datasets, respectively).

In order to perform a GSEA for the differentially expressed genes obtained using any of the fitted models, for each cell type, we ranked the genes by the *p*-value of the estimated effect and used that as an input to the fgsea function in the fgsea \[[@pbio.3000528.ref041]\] R \[[@pbio.3000528.ref032]\] package. We used the Hallmark gene sets of the MSigDB collection \[[@pbio.3000528.ref042]\] for GSEAs, with the exception of the *Ltf*-high neutrophil expression-change GSEAs, in which we used the gene ontology (GO) biological pathways sets \[[@pbio.3000528.ref043],[@pbio.3000528.ref044]\]. In all GSEAs, we performed multiple hypotheses *p*-value adjustments \[[@pbio.3000528.ref045]\] separately for each cell type. Although not as conservative as adjusting the *p*-values across all cell types, the latter approach would suffer from being imbalanced between the two species, for which a different number of cell types was tested. To perform intra- and interspecies comparisons between proportions of cell types, we fitted a multinomial regression (similar to the mixed-effects models fitted to the expression data, except for the sample random effect) implemented by the nnet \[[@pbio.3000528.ref046]\] R \[[@pbio.3000528.ref032]\] package.

In order to estimate the cell trajectories of the *Ltf*-high neutrophils and neutrophils in the NM-R spleen and circulating immune cells, we applied RNA velocity \[[@pbio.3000528.ref047]\] only to these two clusters, separately for the NM-R datasets of the spleen and circulating immune cells, where in each it was applied separately for the saline control and LPS challenge (total of four analyses).

Comparative splenic histomorphology and fluorescent ISH {#sec018}
-------------------------------------------------------

We investigated the histomorphology and expression of four genes in the spleen of four NM-Rs (two males, two females) and four C57BL/6 mice (two males, two females). Organ collection was performed as described above and spleens were immediately transferred into 10% neutral-buffered formalin. Following fixation, all samples were trimmed, routinely processed, embedded, and sectioned at 4-μm thickness in an RNase-free environment. Consecutive tissue sections were stained with hematoxylin and eosin (HE) and periodic acid--Schiff (PAS), and the expression of *Cd3e*, *Cd19*, *Cd14*, and *Rpl13a* was determined by fluorescent ISH (ViewRNA, Invitrogen, Waltham, MA). The expression of the bacterial gene *dapB* was determined as a negative control.

Samples were stained with DAPI to visualize individual cell nuclei, and the RNA ISH assay was performed according to the Invitrogen ViewRNA ISH Tissue protocol and optimized with the following conditions: heat treatment for 10 minutes at 90--95°C and protease digestion at 1:100 dilution for 20 minutes at 40°C. Hybridization was performed for 2 hours at 40°C using the following species-specific probes: Mouse: *Cd14* (\#VB1-3028230), *Cd3e* (\#VB1-16980), *Cd19* (\#VB1-3028231), *Rpl13a* (\#VB1-16196); NM-R: *Cd14* (\#VF1-4355532), *Cd3e* (\#VF1-6000573), *Cd19* (\#VF1-4359165), *Rpl13a* (\#VF1-4348271) (all probes from ThermoFisher, Waltham, MA).

ISH data analysis {#sec019}
-----------------

Whole slide images were generated in fluorescence using Pannoramic SCAN (3D Histech, Budapest, Hungary). Image analysis data were generated by automated analysis of whole slide images using ImageDx (Reveal Biosciences, San Diego, CA), an integrated whole slide image management and automated image analysis workflow. Briefly, each image is first assessed for quality using a focus measurement followed by an accuracy check. All tissue and staining artifacts are digitally excluded from the quantification. The analysis process includes automated identification of tissue, followed by segmentation of regions of interest and then classification of each cell. The total number of cells is determined by detection of DAPI-positive nuclei. Both the number of positive staining cells and the number of positive regions within each cell are recorded. For a positive staining cell, the number of cells is provided for each number of puncta, ranging from 1 to 9 and 10 or more (i.e., ten bins).

Using the number of puncta to distinguish between cell types comes with uncertainty because one cannot exclude the possibility that cells with even a single hybridized probe (i.e., puncta = 1) are really negative for the cell type of which this probe is a marker. Clearly, this uncertainty may affect a test for determining whether mouse and NM-R spleens have different proportions of each of the three cell types targeted by each probe. In order to account for this uncertainty, for each of the ten puncta bins except for the first, we defined negative cells as those with less than the puncta bin and positive as cells with that number of puncta or higher, and fit a multinomial regression, implemented by the nnet \[[@pbio.3000528.ref046]\] R \[[@pbio.3000528.ref032]\] package, quantifying a species categorical effect, with mouse set as baseline. The uncertainty arising because of selection of a specific puncta bin was propagated by specifying the mean species effect across all puncta bins divided by its standard error as a z-statistic. This allowed obtaining a *p*-value, which thus served as the statistical significance of the species effect, across all puncta bins, being different from 0.

Comparative histomorphology of peripheral blood smears {#sec020}
------------------------------------------------------

Peripheral blood smears were generated from two young female guinea pigs (approximately 2 years old) and five young nonbreeding NM-Rs (2--15 months old; 3 males and 2 females). Samples were drawn via cardiocentesis and streaked onto glass slides. Smears were air-dried and stained with Wrights-Giemsa. For each sample, the histomorphology of peripheral blood cells was assessed at 60× by a board-certified veterinary anatomic pathologist (DMI) for the presence of Foa-Kurloff cells.

RNA isolation {#sec021}
-------------

One milliliter TRIzol reagent (4°C) (Invitrogen 15596026, Waltham, MA) was added to approximately 20 mg frozen splenic tissue in a 2-mL microcentrifuge tube. A single stainless steel bead (Qiagen 69965, Hilden, Germany) was added to each tube, and tissue homogenization was performed using a Tissuelyser II (Qiagen, Hilden, Germany) (30 Hz for 2 minutes). RNA was isolated according to manufacturer's instructions (TRIzol, Invitrogen 15596026, Waltham, MA) and resuspended in RNase free water. Contaminating gDNA was removed using the Turbo DNA-free kit (Invitrogen AM1097, Waltham, MA) according to the manufacturer's instructions. Quantification was performed using the QuBit 4 Fluorometer (Invitrogen, Waltham, MA) and the Qubit RNA XR assay (Invitrogen Q33224, Waltham, MA).

Whole spleen RNA library preparation, sequencing, and data analysis {#sec022}
-------------------------------------------------------------------

RNA-seq libraries from the whole splenic tissues were prepared using purified RNA isolated as described above. RNA quality and concentration were assayed using a 5200 Fragment Analyzer instrument (Agilent, Santa Clara, CA). RNA-seq libraries were prepared using the TruSeq Stranded Total RNA kit paired with the Ribo-Zero rRNA removal kit (Illumina, San Diego, CA). Libraries were sequenced on an HiSeq 4000 instrument (Illumina, San Diego, CA). Reads were mapped to the NM-R genomic references described above for the scRNA-seq data using the STAR aligner version 2.5.3a \[[@pbio.3000528.ref048]\], applying the two-round read-mapping approach with the following parameters: outSAMprimaryFlag = "AllBestScore", outFilterMultimapNmax = "10", outFilterMismatchNoverLmax = "0.05", outFilterIntronMotifs = "RemoveNoncanonical".

Following read mapping, transcript and gene expression levels were estimated using MMSEQ \[[@pbio.3000528.ref049]\]. Transcripts and genes that were minimally distinguishable according to the read data were collapsed using the mmcollapse utility of MMDIFF \[[@pbio.3000528.ref050]\], and the fragments per kilobase million (FPKM) expression units were converted to TPM units. In order to test for differential expression between LPS-challenged and saline control tissues, for each species, we used MMDIFF with these two-group design matrices: \# M 0, 0, 0, 0; \# C 0 0, 0 0, 0 1, 0 1; \# P0 1; \# P1 0.5 −0.5. Samples were clustered using the heatmap.2 function from the gplots \[[@pbio.3000528.ref051]\] R \[[@pbio.3000528.ref032]\] package, for the purpose of constructing the genes-by-samples heatmaps for both species. GSEAs were performed for each species, for which the inputs to the fgsea function in the fgsea \[[@pbio.3000528.ref041]\] R \[[@pbio.3000528.ref032]\] package were the genes ranked in descending order according to the Bayes Factor and posterior probability reported by MMDIFF, and the gene sets were the Hallmark gene sets of the MSigDB collection \[[@pbio.3000528.ref042]\].

Supporting information {#sec023}
======================

###### Overview of scRNA-seq and transcriptional maps of mouse and NM-R spleens.

**(A)** Schematic view showing the workflow in which single-cell suspensions are derived from four (two males \[M\], two females \[F\]) C57BL/6 mouse spleens. **(B)** Bar chart showing the number of cells sequenced in duplicate from each of the four mouse spleens (see [S43 Table](#pbio.3000528.s055){ref-type="supplementary-material"} for underlying data). **(C)** Violin plot showing the number of genes sequenced per cell from each of the four mouse spleens (see [S1 Table](#pbio.3000528.s013){ref-type="supplementary-material"} for underlying data). **(D)** Violin plot showing the number of UMIs sequenced per cell from each of the four mouse spleens (see [S1 Table](#pbio.3000528.s013){ref-type="supplementary-material"} for underlying data). **(E)** UMAP projection of the four-mouse spleen scRNA-seq data, for which each point is a cell color-coded by its converged-cluster assignment and annotated cell type. **(F)** Gene-by-cell expression-level heatmap of the four-mouse spleen scRNA-seq data, in which selected marker genes are listed to the left and cells are faceted by their converged cluster assignment. **(G)** Stacked bar chart showing the proportion (%) of cells from each of the four mouse duplicate spleen samples assigned to each of the converged clusters (see [S1 Table](#pbio.3000528.s013){ref-type="supplementary-material"} for underlying data). Samples are color-coded and duplicates are shade-coded. **(H)** Schematic view showing the workflow in which single-cell suspensions are derived from four (two males \[M\], two females \[F\]) NM-R spleens. **(I)** Bar chart showing the number of cells sequenced in duplicate from each of the four NM-R spleens (see [S43 Table](#pbio.3000528.s055){ref-type="supplementary-material"} for underlying data). **(J)** Violin plot showing the number of genes sequenced per cell from each of the four NM-R spleens (see [S2 Table](#pbio.3000528.s014){ref-type="supplementary-material"} for underlying data). **(K)** Violin plot showing the number of UMIs sequenced per cell from each of the four NM-R spleens (see [S2 Table](#pbio.3000528.s014){ref-type="supplementary-material"} for underlying data). **(L)** UMAP projection of the four NM-R spleen scRNA-seq data, for which each point is a cell color-coded by its converged-cluster assignment and annotated cell type. **(M)** Gene-by-cell expression-level heatmap of the four NM-R spleen scRNA-seq data, in which selected marker genes are listed to the left and cells are faceted by their converged cluster assignment. **(N)** Stacked bar chart showing the proportion (%) of cells from each of the four NM-R duplicate spleen samples assigned to each of the converged clusters (see [S2 Table](#pbio.3000528.s014){ref-type="supplementary-material"} for underlying data). Samples are color-coded and duplicates are shade-coded. DC, dendritic cell; MZ, marginal zone; NK, natural killer; NKT, natural killer T; NM-R, naked mole-rat; RP, red pulp; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection; UMI, unique molecular identifier.

(TIF)

###### 

Click here for additional data file.

###### Differences in splenic microarchitecture and gene expression as measured by ISH recapitulate the differences observed in scRNA-seq data.

**(A)** Representative images of HE-stained consecutive sections of mouse (upper panel) and NM-R (lower panel) spleens shown at 5× (left panels) and 20× magnifications (right panels), scale bar = 100 μm. Mouse and NM-R spleens show major differences in splenic microanatomy, with the NM-R having a comparatively reduced white-pulp compartment and a larger red-pulp compartment with a greater number of fibromuscular trabeculae that connect to the capsule and provide structural support and contractility to the spleen. Within the white pulp, the marginal zone and follicles of the NM-R (which comprise B cells) are readily identifiable. By contrast, the PALS (which comprises the T cell--rich compartment in other species) is less prominent in the NM-R than in the mouse. **(B)** UMAP projections of the mouse (upper panels) and NM-R (lower panels) spleen scRNA-seq data color-coded by the expression levels of myeloid and lymphoid lineage marker genes: *Cd14* (myeloid marker), *Cd19* (B cell marker, lymphoid), and *Cd3e* (T cell marker, lymphoid). **(C)** Representative consecutive sections of mouse (upper panel) and NM-R (lower panel) spleens showing results from ISH staining for *Cd14*, *Cd19*, and *Cd3e*. Positive expression of the marker genes was visualized with a TRITC filter (yellow) and nuclei visualized using DAPI staining (blue). Magnification, 20×. Scale bar = 100 μm. Expression of the housekeeping gene *Rpl13a* and the bacterial-specific *dapB* gene were included as positive and negative controls, respectively (Materials and methods). **(D)** Quantification of the ISH staining of *Cd14*, *Cd19*, and *Cd3e* in mouse (gray bars) and NM-R (pink bars). Bars represent the proportion of positive staining cells (*n* = 4 biological replicates) and error bars represent the uncertainty associated with the number of puncta used as a cutoff for defining a cell as positive for a marker gene (Materials and methods and [S5 Table](#pbio.3000528.s017){ref-type="supplementary-material"} for underlying data). Asterisks mark statistically significant (adjusted *p* \< 0.05) differences in cell type proportions. Consistent with our findings from the scRNA-seq data, ISH showed a significantly higher level of *Cd14* in the NM-R compared with the mouse, with staining restricted to the red-pulp regions in both species. However, the NM-R has significantly lower abundance of *Cd19*, with positive staining cells localized to the follicular regions of the white pulp. Compared with the dramatic differences in the abundance of *Cd14* and *Cd19*, the abundance of *Cd3e* is similar between the two species, which is in line with our scRNA-seq data. Despite their similar abundance, the distribution of *Cd3e* positive staining cells is markedly different between the two species, with *Cd3e* expression in the mouse limited to the PALS, while that of the NM-R is stochastically distributed throughout both the red- and white-pulp regions, with only minimal aggregation in the PALS. Thus, direct examination of splenic tissue from mouse and NM-R highlights major differences in microanatomy between the two species and supports our results from the scRNA-seq data with respect to the proportions of the major immune cell lineages in the two species. APC, antigen-presenting cell; DC, dendritic cell; HE, hematoxylin and eosin; ISH, in situ hybridization; NK, natural killer; NM-R, naked mole-rat; PALS, periarteriolar lymphoid sheath; scRNA-seq, single-cell RNA-sequencing; TRITC, tetramethylrhodamine; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Expression of canonical NK cell marker genes in the NM-R spleen is confined to T-cell subsets and mast cells.

**(A)** UMAP projections of the four NM-R spleens scRNA-seq data color-coded by the expression levels of three canonical NK cell marker genes: *Nkg7*, *Gzma*, and *Ccl5*. **(B)** Violin plots showing the expression levels of the CD3 subunit genes: *Cd3d*, *Cd3e*, *Cd3g*, *Cd247*, and of *Cd8a* in the mouse T-cell and NK cell converged clusters (left panel) and NM-R T-cell converged clusters (center panel). The side panels show effect sizes for expression-level changes and expression-induction changes, where in the mouse, the naïve CD8 T cells are used as baseline and in the NM-R, the naïve T cells are used as baseline (see [S6 Table](#pbio.3000528.s018){ref-type="supplementary-material"} for underlying data). Asterisks mark adjusted *p* \< 0.05. **(C)** UMAP projections of the four NM-R spleens scRNA-seq data color-coded by the expression levels of three mast cells marker genes: *Tpsab1*, *Cma1*, and *Fcer1a*. CD3, cluster of differentiation 3; Mem, memory; NK, natural killer; NKT, natural killer T; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### scRNA-seq of mouse and NM-R circulating immune cells confirms absence of canonical NK cells in the NM-R.

**(A)** Schematic view showing the workflow in which single-cell suspensions are derived from circulating immune cells of four (two males \[M\], two females \[F\]) mice (upper panel, gray) and four NM-Rs (two males \[M\], two females \[F\]) (lower panel, pink). **(B)** Bar charts showing the number of cells sequenced from each of the four mice (upper panel, gray) and three NM-Rs (one sample was lost due to a microfluidic failure during the emulsion generation; lower panel, pink) (see [S43 Table](#pbio.3000528.s055){ref-type="supplementary-material"} for underlying data). **(C)** Violin plots showing the number of genes sequenced per cell from each of the four mice (upper panel, gray; see [S7 Table](#pbio.3000528.s019){ref-type="supplementary-material"} for underlying data) and three NM-Rs (lower panel, pink; see [S8 Table](#pbio.3000528.s020){ref-type="supplementary-material"} for underlying data). **(D)** Violin plots showing the number of UMIs sequenced per cell from each of the four mice (upper panel, gray; see [S7 Table](#pbio.3000528.s019){ref-type="supplementary-material"} for underlying data) and three NM-Rs (lower panel, pink; see [S8 Table](#pbio.3000528.s020){ref-type="supplementary-material"} for underlying data). UMAP projections of the four mouse (**E**) and three NM-R (**F**) circulating immune scRNA-seq datasets. Each point is a cell color-coded by its first iteration cluster assignment and annotated cell type. The proportions of each cell type are shown in the central bar chart. Gene-by-cell expression-level heatmaps of the four mouse (**G**) and three NM-R (**H**) circulating immune scRNA-seq datasets. Selected marker genes are listed to the left and cells are faceted by their first iteration cluster assignment. DC, dendritic cell; NK, natural killer; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection; UMI, unique molecular identifier.

(TIF)

###### 

Click here for additional data file.

###### Absence of canonical NK cells in the NM-R cannot be explained by annotation deficiencies in the NM-R genome.

One possibility for the absence of NK cells in the NM-R may be that, due to incomplete annotation of NK cell marker genes in the NM-R, genome reads generated from these marker genes would be filtered as a result of not mapping back to the annotated genome. To test this possibility, we simulated a lack of NK cell marker genes in the mouse by selectively eliminating the mouse NK cell marker genes (51 and 43 genes in the spleen and circulating immune cells; [S3](#pbio.3000528.s015){ref-type="supplementary-material"} and [S9](#pbio.3000528.s021){ref-type="supplementary-material"} Tables, respectively) and subsequently re-clustered the mouse data (done both for the spleen data as well as for the circulating immune cells). **(A)** UMAP projection of the four mouse spleen scRNA-seq data color-coded by the first iteration clusters achieved using the full set of genes. **(B)** UMAP projection of the four mouse spleen scRNA-seq data color-coded by the first iteration clusters achieved using the set of genes without the mouse spleen NK cell marker genes. Clusters are labeled by their indices and by the percentage of their cells that map to the cluster/cell type they correspond to in (**A)**. **(C)** UMAP projection of the four mouse circulating immune scRNA-seq data color-coded by the first iteration clusters achieved using the full set of genes. **(D)** UMAP projection of the four mouse circulating immune scRNA-seq data color-coded by the converged clusters achieved using the set of genes without the mouse circulating NK cell marker genes. Clusters are labeled by their indices and by the percentage of their cells that map to the cluster/cell type they correspond to in **(C)**. APC, antigen-presenting cell; NK, natural killer; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Gene expression and histological support for the lack of NM-R canonical NK cells.

**(A)** The amino acid sequence of the NM-R *Ly49* gene (*LOC101714034*; a mouse *Klra1* ortholog) color-coded by its predicted functional domains: extracellular region (green), intracellular region (blue), and transmembrane region (red). The immunoreceptor tyrosine inhibitory motif (ITIM) is shown in pink. **(B)** UMAP projections of the NM-R spleen scRNA-seq data color-coded by clusters (left) and by the expression levels of *LOC101714034* (right), showing its low expression levels in CD8 T cells. **(C)** UMAP projections of the mouse spleen scRNA-seq data color-coded by clusters (left) and by the expression levels of *Klra1* (right), showing its high expression levels in CD8 T cells and NK cells. **(D)** Wrights-Giemsa stained peripheral blood smear (magnification = 60×; scale bar = 25 μm) from a young female guinea pig, with arrows marking Foa-Kurloff cells characterized by a large cuniform cytoplasmic inclusion body, along with two polymorphonuclear neutrophils (top left and center) and a lymphocyte (bottom). **(E-I)** Wrights-Giemsa stained peripheral blood smears (magnification = 60×; scale bar = 25 μm) from five young NM-Rs (\[**E**\] 2-month-old male, \[**F**\] 7-month-old male, \[**G**\] 15-month-old female, \[**H**\] 11-month-old male, \[**I**\] 7-month-old female) showing mainly polymorphonuclear neutrophils and clumped platelets, along with a few lymphocytes, monocytes, and eosinophils with granular cytoplasm, where none of these leukocytes show an overt Foa-Kurloff cell morphology. CD8, cluster of differentiation 8; DC, dendritic cell; NK, natural killer; NKT, natural killer T; NM-R, naked mole-rat; pDC, plasmacytoid dendritic cell; RP, red pulp; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Reconstructing the ancestral counts of NK cell receptor gene families.

**(A)** Stacked bar chart showing the benchmarked percentage of false positive putative NK cell receptor and *MHC-I* pseudogenes (Materials and methods and [S12 Table](#pbio.3000528.s024){ref-type="supplementary-material"} for underlying data) for each gene family (bars), color-coded by the genome of the search species. Labeled on top of each bar is (number of false positives)/(number of true + false positives). Horizontal black dashed line marks the 5% false positive rate. While the high false positive rate in the *LILR* and *KIR* gene families is driven by many of the search genomes, for the remaining gene families the main drivers of the false positive rate are the platypus and donkey search genomes (orange and purple shades, respectively). **(B)** A similar stacked bar chart as **(A)** with the platypus and donkey search genomes removed, showing that in the gene families other than *LILR* and *KIR*, all gene families except for *KLRK* have either a single false positive or a false positive rate \<5%. **(C-L)** Phylogenies of the 48 mammalian genomes; each corresponds to one of the NK cell receptor gene families within the *NKC* (except for *KLRA*): *KLRG* (**C**), *KLRB* (**D**), *KLRE* (**E**), *KLRF* (**F**), *KLRD* (**G**), *KLRK* (**H**), *KLRC* (**I**), *KLRJ* (**J**), *KLRI* (**K**), and *KLRH* (**L**). Color shades correspond to the numbers of genes. Because the ancestral reconstruction is not deterministic, ancestral counts are represented as pie charts corresponding to the probability of each count. *KIR*, killer cell immunoglobulin-like receptor; *KLR*, killer cell lectin-like receptor; *LILR*, leukocyte immunoglobulin-like receptor; *MHC-I*, major histocompatibility complex class I; NK, natural killer; *NKC*, natural killer cell receptor complex.

(TIF)

###### 

Click here for additional data file.

###### Whole-spleen RNA sequencing of mice and NM-Rs following LPS challenge.

**(A)** Genes-by-samples heatmap showing the scaled ln(TPM) expression levels of genes in spleens from the two saline control and two LPS-challenged mice. Selected LPS up-regulated genes are shown to the left. **(B)** Genes-by-samples heatmap showing the scaled ln(TPM) expression levels in spleens from the two saline control and two LPS-challenged NM-Rs. Selected LPS up-regulated genes are shown to the right. **(C)** Volcano plot showing the posterior probability of the estimated effect size (ln(LPS/saline) ln(TPM) fold-change) being different from zero (y-axis) versus the estimated effect size (x-axis) in the mouse data. Each point is a gene, and the color code follows the posterior probability gradient. **(D)** Volcano plot showing the posterior probability of the estimated effect size (ln(LPS/saline) ln(TPM) fold-change) being different from zero (y-axis) versus the estimated effect size (x-axis) in the NM-R data. Each point is a gene, and the color code follows the posterior probability gradient. **(E)** Bar chart showing the Hallmark gene sets enriched in genes with strong expression changes following LPS challenge in mice (see [S16 Table](#pbio.3000528.s028){ref-type="supplementary-material"} for underlying data). The x-axis reports the log~10~-adjusted *p*-value (*q*-value) of the GSEA, signed by the direction of the effect (up- and down-regulation in LPS relative to saline are represented as follows: positive is yellow and negative is cyan, respectively). Vertical dashed lines represent adjusted *p* = 0.1. **(F)** Bar chart showing the Hallmark gene sets enriched in genes with strong expression changes following LPS challenge in NM-Rs (see [S17 Table](#pbio.3000528.s029){ref-type="supplementary-material"} for underlying data). The x-axis reports the log~10~-adjusted *p*-value (*q*-value) of the GSEA, signed by the direction of the effect (up- and down-regulation in LPS relative to saline are represented as follows: positive is yellow and negative is cyan, respectively). Vertical dashed lines represent adjusted *p* = 0.1. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat; TPM, transcripts per million.

(TIF)

###### 

Click here for additional data file.

###### Cell-specific responses to LPS challenge in the NM-R and mouse spleen.

Marked transcriptional responses were evident following LPS challenge for each cell type compared between the LPS-challenged and saline control animals in each of the species. As previously described by Shalek and colleagues \[[@pbio.3000528.ref052]\], these LPS-responsive transcriptional changes were driven by expression-level change (a change in the level of the expression among the cells that express a given gene in both conditions) and/or expression-induction change (a change in the proportion of cells expressing a certain gene in both conditions), illustrated here by the transcriptional changes of *Nfkbia*. **(A)** Selected density plots showing the expression distribution of *Nfkbia* from saline control (orange) and LPS-challenged (red) mice across the cells of five representative cell types. Insets show the estimated LPS-challenge expression-level change (Exp.) and expression-induction change (Ind.) effect sizes (LPS relative to saline) (asterisks mark adjusted *p* \< 0.05). **(B)** Selected density plots showing the expression distribution of *Nfkbia* from saline control (orange) and LPS-challenged (red) NM-Rs across the cells of five representative cell types. Insets show the estimated LPS-challenge expression-level change (Exp.) and expression-induction change (Ind.) effect sizes (LPS relative to saline) (asterisks mark adjusted *p* \< 0.05). **(C)** Heatmap showing the estimated LPS-challenge effect statistics for expression-level change. Selected marker genes are shown to the left. **(D)** Heatmap showing the estimated LPS-challenge effect statistics for expression-induction change. Selected marker genes are shown to the right. **(E)** Bar chart showing the GSEAs of the intraspecies LPS-challenge effect on expression-level change in mouse NK cells (see [S26 Table](#pbio.3000528.s038){ref-type="supplementary-material"} for underlying data). The x-axis is the GSEA log~10~-adjusted *p*-values (*q*-values), signed and color-coded by the direction of the effect (up- and down-regulation in LPS-challenge relative to saline control are represented as yellow and cyan, respectively). Black vertical dashed lines mark *q* = 0.1. **(F)** Heatmap showing GSEAs of the intraspecies LPS-challenge effect on expression-induction change in mice across the listed cell types (see [S27 Table](#pbio.3000528.s039){ref-type="supplementary-material"} for underlying data). The GSEA log~10~-adjusted *p*-values (*q*-values) are color-coded by the direction of the effect (up- and down-regulation in LPS relative to saline: yellow and cyan, respectively) and shaded by the effect *q*-value. Gene sets with *q* \< 0.1 are indicated with an asterisk. **(G)** Heatmap showing GSEAs of the intraspecies LPS-challenge on expression-induction change in NM-Rs across the listed cell types (see [S28 Table](#pbio.3000528.s040){ref-type="supplementary-material"} for underlying data). The GSEA log~10~-adjusted *p*-values (*q*-values) are color-coded by the direction of the effect (up- and down-regulation in LPS relative to saline are represented as yellow and cyan, respectively) and shaded by the effect *q*-value. Gene sets with *q* \< 0.1 are indicated with an asterisk. APC, antigen-presenting cell; B, B cell; GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; Mono, monocyte; Neut, neutrophil; *Nfkbia*, nuclear factor kappa-light-chain-enhancer of activated B cells inhibitor alpha; NK, natural killer; NM-R, naked mole-rat; T, T cell.

(TIF)

###### 

Click here for additional data file.

###### Circulating immune scRNA-seq reveals that NM-Rs have an LPS-responsive cell subset not found in mice.

UMAP projections showing the clusters of the circulating immune cells from the two saline control (left panel) and two LPS-challenged (right panel) mice (**A**) and NM-Rs (**B**). Each point is a cell color-coded by its cluster assignment and annotated cell type. Stacked bar charts showing the proportions (%) of each cell type in the saline control (top) and LPS-challenged (bottom) mouse (**C**) and NM-R (**D**) circulating immune cells. Similar to the spleen saline control and LPS challenge data ([S9 Fig](#pbio.3000528.s009){ref-type="supplementary-material"}), marked transcriptional responses were evident following LPS challenge for each cell type compared between the LPS-challenged and saline control animals in each of the species. And these changes were again driven by expression-level changes and/or expression-induction changes, illustrated here by the transcriptional changes of *Nfkbia*. **(E)** Selected density plots showing the expression distribution of *Nfkbia* from saline control (orange) and LPS-challenged (red) mice across the cells of five representative cell types. Insets show the estimated LPS-challenge expression-level change (Exp.) and expression-induction change (Ind.) effect sizes (LPS relative to saline) (asterisks mark adjusted *p* \< 0.05). **(F)** Selected density plots showing the expression distribution of *Nfkbia* from saline control (orange) and LPS-challenged (red) NM-Rs across the cells of five representative cell types. Insets show the estimated LPS-challenge expression-level change (Exp.) and expression-induction change (Ind.) effect sizes (LPS relative to saline) (asterisks mark adjusted *q* \< 0.05). **(G)** Heatmap showing the estimated LPS-challenge effect statistics for expression-level change. Selected marker genes are shown to the left. **(H)** Heatmap showing the estimated LPS-challenge effect statistics for expression-induction change. Selected marker genes are shown to the right. **(I)** Bar chart showing the GSEAs of the intraspecies LPS-challenge effect on expression-level change in mouse NK cells (see [S39 Table](#pbio.3000528.s051){ref-type="supplementary-material"} for underlying data). The x-axis is the GSEA log~10~-adjusted *p*-values (*q*-values) signed and color-coded by the direction of the effect (up- and down-regulation in LPS-challenge relative to saline control are represented by yellow and cyan, respectively). Black vertical dashed lines mark *q* = 0.1. **(J)** Heatmap showing GSEAs of the intraspecies LPS-challenge effect on expression-induction change in mice across the listed cell types (see [S40 Table](#pbio.3000528.s052){ref-type="supplementary-material"} for underlying data). The GSEA log~10~-adjusted *p*-values (*q*-values) are color-coded by the direction of the effect (up- and down-regulation in LPS relative to saline are represented as yellow and cyan, respectively) and shaded by the effect *q*-value. Gene sets with *q* \< 0.1 are indicated with an asterisk. **(K)** Heatmap showing GSEAs of the intraspecies LPS-challenge on expression-induction change in NM-Rs across the listed cell types (see [S41 Table](#pbio.3000528.s053){ref-type="supplementary-material"} for underlying data). The GSEA log~10~-adjusted *p*-values (*q*-values) are color-coded by the direction of the effect (up- and down-regulation in LPS relative to saline are represented by yellow and cyan, respectively) and shaded by the effect *q*-value. Gene sets with *q* \< 0.1 are indicated with an asterisk. UMAP projections showing cell clusters representing *Ltf*-high neutrophils (pink) and neutrophils (yellow) from saline control (**L**) and LPS-challenged (**M**) NM-R circulating immune cells. Overlaid on each cluster are arrows that represent the cell trajectory (Materials and methods). **(N)** Bar chart showing GSEA comparing circulating *Ltf*-high neutrophils to neutrophils in LPS-challenged NM-Rs (see [S42 Table](#pbio.3000528.s054){ref-type="supplementary-material"} for underlying data). The x-axis is the GSEA log~10~-adjusted *p*-values (*q*-values), signed and color-coded by the direction of the effect (up- and down-regulation in *Ltf*-high neutrophils versus neutrophils are represented by yellow and cyan, respectively). Black vertical dashed lines mark adjusted *p* = 0.1. B, B cell; Ery, erythroid cell; GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; Mono, monocyte; Neut, neutrophil; *Nfkbia*, nuclear factor kappa-light-chain-enhancer of activated B cells inhibitor alpha; NK, natural killer; NM-R, naked mole-rat; RBC, red blood cell; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Hemoglobin gene expression in the spleen scRNA-seq data.

UMAP projections of the clusters of the NM-R and mouse spleen datasets color-coded by the expression levels of **(A)** NM-R beta hemoglobin, **(B)** NM-R gamma hemoglobin, **(C)** NM-R epsilon hemoglobin, **(D)** NM-R alpha hemoglobin, **(E)** NM-R theta hemoglobin, **(F)** NM-R zeta hemoglobin, **(G)** mouse beta-s hemoglobin, **(H)** mouse beta-t hemoglobin, **(I)** mouse alpha-1 hemoglobin, and **(J)** mouse alpha-2 hemoglobin. **(K)** Violin plot showing the numbers of genes expressed in each of the NM-R spleen converged clusters (right panel) and a plot showing the effect sizes comparing the number of genes in each of the NM-R converged clusters to the mean across all converged clusters (right panel; see [S45 Table](#pbio.3000528.s057){ref-type="supplementary-material"} for the underlying data). Asterisks mark adjusted *p* \< 0.05. DC, dendritic cell; NM-R, naked mole-rat; RP, red pulp; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Hemoglobin gene expression in the immune circulating scRNA-seq data.

UMAP projections of the clusters of the NM-R and mouse circulating immune cell datasets color-coded by the expression levels of **(A)** NM-R beta hemoglobin, **(B)** NM-R gamma hemoglobin, **(C)** NM-R epsilon hemoglobin, **(D)** NM-R alpha hemoglobin, **(E)** NM-R theta hemoglobin, **(F)** NM-R zeta hemoglobin, **(G)** mouse beta-s hemoglobin, **(H)** mouse beta-t hemoglobin, **(I)** mouse alpha-1 hemoglobin, and **(J)** mouse alpha-2 hemoglobin. **(K)** Violin plot showing the numbers of genes expressed in each of the converged clusters of the NM-R circulating immune cells data (right panel) and a plot showing the effect sizes comparing the number of genes in each of the NM-R converged clusters to the mean across all converged clusters (right panel; see [S46 Table](#pbio.3000528.s058){ref-type="supplementary-material"} for the underlying data). Asterisks mark adjusted *p* \< 0.05. DC, dendritic cell; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMAP, uniform manifold approximation and projection.

(TIF)

###### 

Click here for additional data file.

###### Mouse spleen scRNA-seq clustering data.

For each mouse spleen cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R spleen scRNA-seq clustering data.

For each NM-R spleen cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse spleen scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R spleen scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Spleen in situ data.

For each mouse and NM-R sample, provided for each probe gene are the species, sample, number of puncta bin, cell count, and cell area. NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Differential expression of the CD3 subunit genes: *Cd3d, Cd3e, Cd3g, Cd247*, and of *Cd8a* among mouse and NM-R clusters.

For each differential expression contrast (for each gene in each converged cluster), provided are the gene symbol, converged cluster cell type, species, test (differential induction or expression), effect size, standard error of effect size, *p*-value, and adjusted *p*-value (*q*-value). CD3, cluster of differentiation 3; NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Mouse circulating immune scRNA-seq clustering data.

For each mouse circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R circulating immune scRNA-seq clustering data.

For each NM-R circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse circulating immune scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R circulating immune scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Data corresponding to [Fig 2A--2C](#pbio.3000528.g002){ref-type="fig"} showing the genes in the *LRC*, *NKC*, and *MHC-I* region of the human, mouse, and NM-R genomes.

For each species, for each gene (protein coding, annotated, and putative pseudogenes) provided are the gene ID (Ensembl for all species except NM-R, for which it is RefSeq), gene symbol, gene biotype, genome scaffold name, start site, end site, and gene family. *LRC*, leukocyte receptor complex; *MHC-I*, major histocompatibility complex class I; *NKC*, natural killer cell receptor complex; NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Benchmarking the detection of putative pseudogenes in the *LRC*, *NKC*, and *MHC-I* region.

For each species, for each gene family, provided are the species and gene ID (Ensembl for all species except NM-R, for which it is RefSeq) of the genes used as query, the hit gene ID, symbol, and family. *LRC*, leukocyte receptor complex; *MHC-I*, major histocompatibility complex class I; *NKC*, natural killer cell receptor complex; NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Phyletic pattern data of the protein-coding genes, annotated pseudogenes, and putative pseudogenes in the *LRC*, *NKC*, and *MHC-I* region.

For each species, for each gene (protein coding, annotated and putative pseudogene) provided are the gene ID (Ensembl for all species except NM-R, for which it is RefSeq), gene symbol, gene family, biotype, genome scaffold name, start and end site. *LRC*, leukocyte receptor complex; *MHC-I*, major histocompatibility complex class I; *NKC*, natural killer cell receptor complex; NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Mouse whole spleen RNA-sequencing LPS challenge versus saline control differential expression.

For each expressed gene provided are its Ensembl ID, symbol, description, biotype, Entrez ID; estimated ln fold-change, its posterior probability of being different from zero, and a Bayes factor of the differential expression model versus a null model; the ln(TPM) of each sample, the mean and standard deviation of the ln(TPM) across the samples of each condition, and the number of uniquely mapped reads in each sample. LPS, lipopolysaccharide.

(CSV)

###### 

Click here for additional data file.

###### NM-R whole spleen RNA-sequencing LPS challenge versus saline control differential expression.

For each expressed gene provided are its RefSeq ID, symbol; estimated ln fold-change, its posterior probability of being different from zero, and a Bayes factor of the differential expression model versus a null model; the ln(TPM) of each sample, the mean and standard deviation of the ln(TPM) across the samples of each condition, and the number of uniquely mapped reads in each sample. LPS, lipopolysaccharide; NM-R, naked mole-rat; TPM, transcripts per million.

(CSV)

###### 

Click here for additional data file.

###### Mouse whole spleen RNA-sequencing LPS challenge versus saline control GSEA.

For each enriched gene set provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (up or down), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide.

(CSV)

###### 

Click here for additional data file.

###### NM-R whole spleen RNA-sequencing LPS challenge versus saline control GSEA.

For each enriched gene set provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (up or down), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Mouse saline control spleen scRNA-seq clustering data.

For each mouse saline control spleen cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge spleen scRNA-seq clustering data.

For each mouse LPS challenge spleen cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R saline control spleen scRNA-seq clustering data.

For each NM-R spleen saline control cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge spleen scRNA-seq clustering data.

For each NM-R spleen LPS challenge cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse saline control spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse spleen saline control scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse spleen LPS challenge scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R saline control spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R spleen saline control scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge spleen scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R spleen LPS challenge scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge versus saline control spleen scRNA-seq expression change GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (up or down), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge versus saline control spleen scRNA-seq expression induction GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge versus saline control spleen scRNA-seq expression induction GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R spleen saline control *Ltf*-high neutrophils versus neutrophils scRNA-seq expression change GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R spleen LPS challenge *Ltf*-high neutrophils versus neutrophils scRNA-seq expression change GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse saline control circulating immune scRNA-seq clustering data.

For each mouse saline control circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge circulating immune scRNA-seq clustering data.

For each mouse LPS challenge circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R saline control circulating immune scRNA-seq clustering data.

For each NM-R saline control circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge circulating immune scRNA-seq clustering data.

For each NM-R LPS challenge circulating immune cell in our scRNA-seq data, the corresponding sample, number of captured UMIs, number of captured genes, first-iteration and convergence cluster and cell type assignments are provided. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; UMI, unique molecular identifier.

(CSV)

###### 

Click here for additional data file.

###### Mouse saline control circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse saline control circulating immune scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the mouse LPS challenge circulating immune scRNA-seq data, provided are its Ensembl gene ID, gene symbol, gene description, gene biotype, and converged cluster and cell type. LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R saline control circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R saline control circulating immune scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge circulating immune scRNA-seq cluster marker genes.

For each marker gene in each of the converged clusters of the NM-R LPS challenge circulating immune scRNA-seq data, provided are its RefSeq gene ID, gene symbol, and converged cluster and cell type. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge versus saline control circulating immune scRNA-seq expression change GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (up or down), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### Mouse LPS challenge versus saline control circulating immune scRNA-seq expression induction GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge versus saline control circulating immune scRNA-seq expression induction GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R LPS challenge *Ltf*-high circulating neutrophils versus circulating neutrophils scRNA-seq expression change GSEA.

For each cluster, for each enriched gene set, provided are its category description, *p*-value, adjusted *p*-value (*q*-value), test statistic, enrichment direction (on or off), and the Entrez IDs and symbols of the leading-edge genes. GSEA, gene set enrichment analysis; LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### scRNA-seq data summary statistics.

For each scRNA-seq sample provided are the species, sex, tissue, condition, biological replicate, technical replicate, number of reads, percentage of mapped reads, percentage of confidently mapped reads, percentage of confidently mapped intergenic reads, percentage of confidently mapped intronic reads, percentage of confidently mapped exonic reads, percentage of confidently mapped transcriptomic reads, percentage of antisense to gene mapped reads, number of filtered cell-less barcodes, number of multiplet filtered barcodes, number of retained barcodes, number of filtered genes, number of retained genes across all cells, and number of variable genes across the replicates. scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### scRNA-seq clusters annotation.

For each converged cluster in each of the scRNA-seq datasets provided are the Ensembl or RefSeq genes IDs (for mouse and NM-R genes, respectively), ortholog Ensembl gene ID (only for NM-R genes), gene symbol, ortholog gene symbol (only for NM-R genes), converged cluster, converged cell type, ImmGen cell type, ImmGen TPM, species, dataset, and established cell type the gene is associated with. NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing; TPM, transcripts per million.

(CSV)

###### 

Click here for additional data file.

###### Differential number of expressed genes across NM-R spleen cell clusters.

For each differential expressed-gene count contrast (in each converged cluster), provided are the converged cluster cell type, effect size, standard error of effect size, *p*-value, and adjusted *p*-value (*q*-value). NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Differential number of expressed genes across NM-R circulating immune cell clusters.

For each differential expressed-gene count contrast (in each converged cluster), provided are the converged cluster cell type, effect size, standard error of effect size, *p*-value, and adjusted *p*-value (*q*-value). NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### Genomes used for constructing the phyletic pattern.

For each species provided are the species name, phylogenetic group, phylogenetic group type, species scientific name, genome assembly, whether Ensembl was the source, annotation release version, name of GTF file, name of genome sequence fasta file, name of protein sequences fasta file, name of transcript sequences fasta file, name of cDNA sequences fasta file, name of ncRNA sequence fasta file, genome sequence fasta file FTP URL, transcript sequences fasta file FTP URL, protein sequences fasta file FTP URL, cDNA sequences fasta file FTP URL, ncRNA sequences fasta file FTP URL, GTF FTP URL, taxon Entrez ID, assembly level, genome representation level, genome sequence release date, Entrez assembly ID, sequencing technology, genome assembler used, and genome coverage. ncRNA, noncoding RNA.

(CSV)

###### 

Click here for additional data file.

###### NM-R mouse one-to-one gene orthologs.

For each one-to-one NM-R mouse orthologous gene, provided are the NM-R and mouse RefSeq and Ensembl gene IDs, respectively, and their gene symbols. NM-R, naked mole-rat.

(CSV)

###### 

Click here for additional data file.

###### NM-R and mouse LPS challenge and saline control matched spleen scRNA-seq clusters.

For each species in each condition, provided are the original first-iteration cluster and corresponding cell type, and the cluster and cell-type used when the datasets were combined for differential expression analysis, separately for each species. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R and mouse LPS challenge and saline control matched circulating immune scRNA-seq clusters.

For each species in each condition provided are the original first-iteration cluster and corresponding cell type, and the cluster and cell type used when the datasets were combined for differential expression analysis, separately for each species. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R and mouse matched LPS challenge and saline control matched spleen scRNA-seq clusters.

For each species in each condition provided are the original first-iteration cluster and corresponding cell type, and the cluster and cell type used when the datasets were combined for differential expression analysis, for the species combined. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.

###### NM-R and mouse LPS challenge and saline control matched circulating immune scRNA-seq clusters.

For each species in each condition provided are the original first-iteration cluster and corresponding cell type, and the cluster and cell type used when the datasets were combined for differential expression analysis, for the species combined. LPS, lipopolysaccharide; NM-R, naked mole-rat; scRNA-seq, single-cell RNA-sequencing.

(CSV)

###### 

Click here for additional data file.
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Reviewer remarks:

Reviewer \#1 (Ewan St. John Smith, signed review): The study from Hilton et al., is the first to make a comprehensive study of the immune system of the naked mole-rat. Considering the unusual biology of the naked mole-rat, e.g. extreme longevity and general resistance to the processes associated with ageing (as demonstrated through its resistance to cancer and neurodegeneration that are both associated with ageing) it is extremely important to understand more about naked mole-rat immune system, a system that generally deteriorates with ageing.

The authors use unbiased single cell RNA-sequencing of the spleens from mice and naked mole-rats to determine the comparative constituents of the immune systems of these two species. Data acquired from analysis of mouse splenic immune cells are consistent with what others have shown (e.g. a high proportion of lymphoid lineage B and T cells and low proportion of myeloid cells), whereas splenic immune cells of the naked mole-rat form a strikingly different composition, i.e. more myeloid than lymphoid lineage cells (including two subgroups of neutrophils) and an apparent absence of natural killer cells.

Details on the absence of natural killer cells from the spleen are provided and further single cell RNA-sequencing is conducted on circulating immune cells, which, along with efforts to simulate the possible poor annotation of natural killer cell marker genes in the naked mole-rat genome, confirms that naked mole-rats really do appear to lack a natural killer cell population. This finding correlates with a lack of expansion of genes like Ly49 that are associated with natural killer cell function. A broader comparison of 45 mammalian species places the naked mole-rat data in a wider context, demonstrating that the closely related guinea pig has retained control mechanisms for natural killer cells.

The authors next address the comparative gene expression of immune cells following lipopolysaccharide (LPS) injection in mice and naked mole-rats, both species activating similar pathways. However, interestingly, among the two neutrophil subgroups in the naked mole-rat, the naked mole-rat specific high lactotransferrin group increase in number and at the same time there was a convergence of the two groups, a result suggesting that although these two neutrophil subgroups exist with regard to gene transcription, they are in fact likely playing similar roles.

Overall, this is a really exciting paper that documents for the first time the immune system of the naked mole-rat, demonstrating key differences compared to other mammals. Importantly, this work is of a wide general interest and will provoke make future avenues of research e.g. how does the immune system of the naked mole-rat deal with a variety of challenges? This manuscript clearly establishes a platform for all future work to build upon.

Minor comments that should be addressed in a revised version:

\- the authors give the age and sex of animals used, they should also state throughout as to whether or not the mice used were nulliparous, and whether or not the naked mole-rats were breeding or subordinate animals? This is stated for naked mole-rats used for blood smears on line 6 of the Materials and Methods, but not, as far as I can tell, for other parts.

\- naked mole-rats are naturally quite an inbred species, a situation likely pushed further through laboratory housing due to constraints of mixing and matching a species that is, as the authors note, both xenophobic and eusocial. Although such laboratory breeding would likely not explain the striking findings of this paper (e.g. absence of natural killer cells, two neutrophil subgroups and distinct LPS challenge response), it could perhaps influence how well the sequencing data obtained reflect the wild naked mole-rat immune cell transcriptome. Obviously, the same criticism could be aimed at any study using inbred mouse strains, but it would perhaps be helpful to know if animals throughout the study came from the same colony, or different colonies.

\- what evidence do the authors have that markers used for different immune cell subgroups in the mouse are appropriate for use in the naked mole-rat, i.e. for the data in Figure 1A/B, Cxcr2 is used to identify neutrophils -- how robust a marker is this in different species? I do not expect the authors to validate every marker, but a general discussion on this point would, I think, be helpful, especially for the more general reader.

Reviewer \#2 (Pontarotti Pierre, signed review): Review of the article Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity\" by Dr. Nimrod Daniel Rubinstein for PLOS Biology.

In summary the authors show that the naked -mole rat lost the NK cells and corresponding gene during the evolution of the Heterocephalus clade . This is an important finding that can help in the understanding (give more insight) of life longevity and cancer resistance mechanisms. In this regard the choice of the naked mole-rat model is appropriate.

My field is comparative and evolutionary genomic , therefore I have focused on this part of the article .

The in silico analyis (including comparative genomic ) is well described and robust and supports the authors conclusions .

Reviewer \#3: The manuscript entitled "Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity" describes a single cell RNA sequencing analysis of splenic cells in the naked mole rat compared to conventional mice. The interest of NMR is their apparent lower susceptibility to develop tumors. The single cell RNA approach revealed that compared to mice the NMR has fewer B cells and more myeloid cells which skews the ratio lymphoid/myeloid cells that in the mouse is more than 2:1. Two additional features came out of the analysis, one was the apparent lack of NK cells and the other was the detection of a major population of LPS responsive neutrophils not seen in the mouse. This approach is of interest to immunologists and biologists in general. However, the data is solely descriptive and falls short of bringing concrete information on the function of the NMR immune system

Too much relevance is given here to establish a link between the lack of bona fide NK cells, the higher representation of myeloid cells and the low susceptibility to tumors in NMR. The major role of NK cells is a first line of defense to viral infection due to their capacity to detect cells with low or no MHCI expression modulated by many viruses. Tumor immune surveillance has also been described but other adaptive immune cells also play a role (see Smyth et al J. Exp. Med 2000 among others). In fact, recent strategies of cancer immune therapy focus on controlling check points within the adaptive immunity rather than stimulating the ILC compartment. That NMR do not have NK cells is not of major relevance to the discussion because other adaptive immune cells can also secrete cytokines, can take the protective role of NK cells and mechanisms other than immune response related might have evolved in the NMR (cell cycle arrest mechanisms, tumor suppressor genes such as P53 and many other). More relevant in this context is the higher susceptibility of NMR to viral infection.

Because there are fewer B cells, are immunoglobulin levels present in the serum at similar levels? Can memory B and T cells be induced by immunizing with thymus dependent antigens? Are other TLR inducing similar responses? Can antibody responses be induced? Although I understand that this is a short report these would be simple approaches to better characterize the immune system.

Also it should be clarified why there is a large population of erythroid cells found in the NMR and not in the mouse. Because RNA was obtained by total organ lysate this might indicate that in contrast to mouse the NMR erythroid cells have high amounts of RNA. Is the spleen a site of erythroid development in the NMR?

Because the data is deposited in GEO are 48 Sup Tables needed?

Reviewer \#4 (Jim Kaufman, signed review): This manuscript describes single cell RNAseq studies on spleen and blood cells of the naked mole rats in comparison with an inbred mouse strain, both unstimulated and after LPS treatment (as well as a big meta-analysis of gene copy number and a cell staining experiment). I am no expert on such single cell sequencing (although there is no escape from learning about it from many publications and seminars), but there is no question in my mind that this study is worthy of publication in a general high-impact journal of biology. Naked-mole rats are fascinating creatures with many unusual and unexplained characteristics, there is an enormous amount of work done in this paper which seems very well controlled, the results are extremely interesting and novel, the speculations will excite new functional experiments, and the manuscript is very carefully and well-written, so I would predict that this excellent paper will be cited in all studies about this fascinating creature in several different scientific fields for years to come.

I have only two concerns for the authors to consider.

The first concern I believe that the authors should answer. They identify macrophages, red pulp macrophages and (Timeless-high) dendritic cells in the naked mole rat spleen, but only "antigen presenting cells" (APCs) in the mouse. I find this surprising, as the APCs of mice have been well-studied over many decades and so there are certainly RP and other macrophages as well several kinds of DCs in mouse spleen. I also note that the tSNE plots of the mouse cells show a lot of structure in the APC group, so it is well-possible that all these different kinds of cells are represented in that population. Perhaps I missed the key sentence in the text, or the explanation is buried in one of the many supplementary items (of which I looked at only a few), but I think that this point deserves explanation, if only a sentence.

The second concern is more general, but I believe could be dealt with in few sentences. The authors begin their manuscript by describing some of the unexpected features of the naked mole-rat, and their motivation for the study to examine the possibility that "the NM-R has evolved features of systemic immunity that contribute to these remarkable phenotypes." By the end of the discussion, they have certainly shown that \"the NM-R has evolved unusual features of systemic immunity", but I didn't feel that they drew conclusions from their data about the contribution \"to the remarkable phenotypes\". They include three other "histricomorphs" (Damaraland mole-rat, chinchilla and guinea pig) in their meta-analysis, but do not state clearly that their discoveries of cellular composition might be unique to the naked mole-rats or, alternatively, might be an evolutionary novelty for all the "histricomorphs" regardless of their social and ecological traits. Also, they correctly point out that marine carnivores (and dogs, if I remember correctly) also have low levels of NK receptor genes, without exploring the implications (for instance, no or few NK cells apparently does not automatically mean more or less cancer, etc). There is a rich vein of interesting thoughts here with many further experiments to suggest, but I assume the authors wished to avoid a messy discussion and so compressed it all into the single sentence at the end of the discussion. As far as I am concerned, it is up to the authors, but they did leave me wishing for a bit more at the very end.

10.1371/journal.pbio.3000528.r003
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Dear Dr Rubinstein,

On behalf of my colleagues and the Academic Editor, Avinash Bhandoola, I am pleased to inform you that we will be delighted to publish your Short Reports in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Sofia Vickers

Senior Publications Assistant

PLOS Biology

On behalf of,

Di Jiang,

Associate Editor

PLOS Biology
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